![Michael Heffernan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Heffernan
Président chez
AVALO THERAPEUTICS, INC.
Fortune : 337 195 $ au 31/08/2026
Profil
Michael Thomas Heffernan was the founder of Clinical Studies Ltd. (1995), serving as President & Chief Executive Officer from 1995 to 1997.
Mr. Heffernan was the founder of Collegium Pharmaceutical, Inc. (2002), serving as Chairman from 2024 to 2025.
Mr. Heffernan was the founder of Onset Dermatologics LLC (2005), serving as President & Chief Executive Officer from 2005 to 2011.
Mr. Heffernan is the founder of PreCision Dermatology, Inc. (2010), serving as Director from 2010 to 2014.
Mr. Heffernan was the founder of Avenge Bio, Inc. (2019), serving as President, Chief Executive Officer & Director from 2019 to 2024.
Current jobs include Chairman at enGene Therapeutics, Inc. starting 2026, Chairman at NMD Pharma A starting 2023, Chairman at Indalo Therapeutics, Inc. starting 2019, Chairman at Avalo Therapeutics, Inc. starting 2025, Chairman at AAVantgarde Bio Srl, Lead Independent Director at Biohaven Ltd. starting 2020, Independent Director at Trevi Therapeutics, Inc. starting 2023, and Director at K36 Therapeutics, Inc. Former jobs include Chairman, President & Chief Executive Officer at Phymatrix Corp.
from 1999 to 2002, Chairman at Astellas Institute for Regenerative Medicine from 2013 to 2016, Chairman at CTx Operations, Inc., Chairman at Veloxis Pharmaceuticals A from 2016 to 2020, Director at TYRX, Inc., Director at Cornerstone BioPharma, Inc. in 2008, Independent Director at Akebia Therapeutics, Inc. from 2018 to 2022, Independent Director at Chiesi USA, Inc. from 2011 to 2014, Independent Director at Biohaven Pharmaceutical Holding Co. Ltd. from 2020 to 2021, Independent Director at Keryx Biopharmaceuticals, Inc. from 2016 to 2018, Independent Director at Synlogic, Inc. from 2020 to 2025, and Principal at Eli Lilly & Co. Education includes an undergraduate degree from the University of Connecticut, conferred in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOHAVEN LTD. 0,01 % | 28/04/2026 | 15 178 ( 0,01 % ) | 231 768 $ | 31/08/2026 |
| 03/06/2026 | 6 351 ( 0 % ) | 105 427 $ | 31/08/2026 | |
| 16/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 | |
| 02/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Michael Heffernan
| Sociétés | Poste | Début |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2017 |
| BIOHAVEN LTD. | Directeur/Membre du Conseil | 01/01/2020 |
| AVALO THERAPEUTICS, INC. | Président | 25/03/2025 |
| ENGENE THERAPEUTICS INC. | Président | 16/07/2026 |
AAVantgarde Bio Srl
 AAVantgarde Bio Srl BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Président | - |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Directeur/Membre du Conseil | - |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology Discovers and develops novel therapeutics for neuromuscular diseases | Président | 03/01/2023 |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Président | 17/12/2019 |
Anciens postes connus de Michael Heffernan
| Sociétés | Poste | Fin |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Directeur Général | 12/11/2024 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Heffernan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
TYRX, Inc.
 TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology Designs and manufactures medical-pharmaceutical combination devices | Electronic Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cornerstone BioPharma, Inc.
 Cornerstone BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceutical products for respiratory disorders | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
PreCision Dermatology, Inc.
 PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Health Technology |
Clinical Studies Ltd.
 Clinical Studies Ltd. Miscellaneous Commercial ServicesCommercial Services Provides multi-therapeutic, Phase I-IV clinical research studies | Commercial Services |
Phymatrix Corp.
 Phymatrix Corp. Medical/Nursing ServicesHealth Services Operates as a medical practice management company | Health Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
Onset Dermatologics LLC
 Onset Dermatologics LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription products for skin health | Health Technology |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Trevi Therapeutics, Inc.
 Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology Discovers and develops novel therapeutics for neuromuscular diseases | Health Technology |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Health Technology |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Health Technology |
AAVantgarde Bio Srl
AAVantgarde Bio Srl BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Health Technology |
Biohaven Ltd.
 Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
